期刊
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
卷 14, 期 7, 页码 921-927出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1871520614666140127105809
关键词
Acute kidney injury; anti-cancer agents; cisplatin; chemotherapy; electrolyte abnormality; nephrotoxicity
资金
- Japanese Association of Dialysis Physicians JADP [2011-08]
Patients with cancer are frequently exposed to risk of renal injuries associated with disease-related or iatrogenic causes. Nephrotoxicity is a potential adverse effect of anti-cancer agents and may result in a variety of functional abnormalities, including glomerular or tubular dysfunction, hypertension and disturbance of the renal endocrine function. In this review article, we comprehensively discuss the incidence, clinical presentation, prevention and management of anti-cancer agent-induced renal dysfunction. We focus on both relatively new anti-cancer agents (bevacizumab, gefitinib, gemcitabine, imatinib, rituximab and trastuzumab) and traditional agents (cisplatin, methotrexate, ifosfamide and taxanes) to cover a selection of the most frequently used anti-cancer agents. Increased understanding of the mechanism of renal injury by these agents is considered to be important for developing novel anti-cancer agents that have far fewer adverse effects on kidneys.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据